PHAT

Phathom Pharmaceuticals (PHAT)

Phathom Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PHAT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	21 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/05/10	05 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/05/09	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/05/09	21 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/04/29	21 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/04/03	21 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/03/26	21 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/03/08	06 : 01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/03/07	22 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/03/07	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/02/29	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/02/13	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/02/13	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/01/31	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2024/01/23	10 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/12/16	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/12/14	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/12/14	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/12/06	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/12/06	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/28	22 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/28	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/20	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/10	06 : 02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/09	22 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/09	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/09	22 : 00	GlobeNewswire Inc.	Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/09	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/04	05 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PHAT	Phathom Pharmaceuticals Inc
2023/11/02	06 : 50	Dow Jones News	Phathom Pharmaceuticals Gets FDA Approval for Voquezna Treatment	NASDAQ:PHAT	Phathom Pharmaceuticals Inc